Brian Egleston
Biographic Data
| ID | 5537570 |
|---|---|
| NAME | Brian Egleston |
| GIVEN NAMES | Brian |
| FAMILY NAME | Egleston |
| SIGNATURE | EGLESTON B |
| AFFILIATIONS | Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2000 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 0 |
Assessing patient readiness for personalized genomic medicine
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data
BACKGROUND AND OBJECTIVES: The paradoxical rise in overall and cancer-specific mortality despite increased detection and treatment of renal cell carcinoma (RCC) is termed "treatment disconnect." We reassess this phenomenon by evaluating impact of missing data and rising incidence on mortality trends. RESEARCH DESIGN, SUBJECTS, AND MEASURES: Using Surveillance, Epidemiology, and End Results data, we identified patients with RCC diagnosis from 1973…
Effect of Future Costs on Cost-Effectiveness of Medical Interventions Among Young Adults
OBJECTIVES: Recent research based on a lifetime utility maximization model has suggested that cost-effectiveness analyses should account for all future costs, including medical costs for related and unrelated illnesses and nonmedical costs. This work has also shown that analyses that omit future costs are biased to favor interventions among the elderly that extend life over interventions that improve quality of life. However, the effect of includ…
No prominent works on this page.
Effect of Future Costs on Cost-Effectiveness of Medical Interventions Among Young Adults
OBJECTIVES: Recent research based on a lifetime utility maximization model has suggested that cost-effectiveness analyses should account for all future costs, including medical costs for related and unrelated illnesses and nonmedical costs. This work has also shown that analyses that omit future costs are biased to favor interventions among the elderly that extend life over interventions that improve quality of life. However, the effect of includ…
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data
BACKGROUND AND OBJECTIVES: The paradoxical rise in overall and cancer-specific mortality despite increased detection and treatment of renal cell carcinoma (RCC) is termed "treatment disconnect." We reassess this phenomenon by evaluating impact of missing data and rising incidence on mortality trends. RESEARCH DESIGN, SUBJECTS, AND MEASURES: Using Surveillance, Epidemiology, and End Results data, we identified patients with RCC diagnosis from 1973…
Assessing patient readiness for personalized genomic medicine
Medicine (3 works) · Nursing (2 works) · Psychological intervention (2 works) · Acknowledgement (1 works) · Bioinformatics (1 works) · Biology (1 works) · BRCA gene mutations in cancer (1 works) · Cancer (1 works) · Cohort (1 works) · Confidentiality (1 works)